Modulating Glucose Tolerance With Dietary Tyrosine

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 7, 2019

Primary Completion Date

January 24, 2020

Study Completion Date

January 24, 2020

Conditions
Glucose Tolerance
Interventions
DIETARY_SUPPLEMENT

Tyrosine (TYR) Supplementation

L-Tyrosine dietary supplement will be provided as 500 mg capsules and 4 (four) 500 mg capsules are to be given before OGTT. The capsules are formed from animal gelatin, and the contents are formulated with magnesium stearate as a flow agent, but without binders, coatings or colorings and also have no added flavorings, sugars, salt, artificial sweeteners, preservatives or salicylates. The capsules are to be administered with less than eight ounces of water to minimize dilution of gastric acidity.

Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Columbia University

OTHER

NCT03872557 - Modulating Glucose Tolerance With Dietary Tyrosine | Biotech Hunter | Biotech Hunter